Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and Everolimus for GvHD Prophylaxis After Stem Cell Transplantation
NCT00117702Phase 3Terminated
- Sponsor
- Technische Universität Dresden
- Start
- Oct 2005
- Primary completion
- May 2008
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus, everolimus in graft-versus-host disease (GVHD), sponsored by Technische Universität Dresden. Started Oct 2005; status: terminated.
02
Drugs
tacrolimuseverolimus
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00117702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117702.